Q4 2017 OPKO Health Inc Earnings Call
Conference Call OPKO Health Inc
OPKO Health Inc Conference call will be held on Mar 1, 2018. During the earnings conference call's session OPKO Health Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact OPKO Health Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
We are a diversified healthcare company that seeks to establish industry-leading positions in large and rapidly growing medical markets. Our diagnostics business includes Bio-Reference Laboratories ("Bio-Reference"), the nation's third-largest clinical laboratory with a core genetic testing business and a 420-person sales force to drive growth and leverage new products, including the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. Our pharmaceutical business features Rayaldee, a treatment for secondary hyperparathyroidism ("SHPT") in patients with stage 3 or 4 chronic kidney disease ("CKD") and vitamin D insufficiency (target March 29, 2016 PDUFA date) and VARUBI(TM) for chemotherapy-induced nausea and vomiting (launched by partner TESARO in November 2015).Read more Conference Call